We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Key issues and questions for charities to consider based on insights from our casework into campaigning and political activity during previous election periods.
You can raise an issue about the service you get from a Disability Confident employer.
Submission dates and how the submissions using the EC decision reliance procedure work.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
How the MHRA processes variations to Marketing Authorisations (MAs)
A speech by Sarah Cardell, CEO of the Competition and Markets Authority (CMA), delivered at the CMA's 10 year anniversary event.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How we assess issues of potential regulatory concern
If you're advertising or marketing, including direct marketing, you must be accurate and honest and follow the advertising codes of practice
Find out what help you can get to develop a whole school or college approach to mental health and wellbeing.
How the MHRA assesses Marketing Authorisation Applications (MAA) for medicines referred under Article 29.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
Introducing the new pre-application service for Nationally Significant Infrastructure Projects.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).